Mayne Pharma Enters Into A Scheme Implementation Deed With Cosette Pharmaceuticals, Inc
Mayne Pharma Group Limited announces that it has entered into a scheme implementation deed with Cosette Pharmaceuticals, Inc. under which Cosette has agreed to acquire 100% of the shares in Mayne Pharma by way of a Scheme of Arrangement at a price of A$7.40 per share.
Learn more
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Mayne Pharma Group Limited. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Mayne Pharma Group Limited a question about this update.